128 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
4192
SynCore BiotechnologyLtd
NT$35.30-0.3%-6.7%NT$1.2bn/aPE3410.2xn/an/a
6535
Lumosa Therapeutics
NT$235.00-4.5%76.0%NT$39.7bNT$230.00PS1049.6xE11.9%n/a
4167
Savior Lifetec
NT$20.60-3.3%3.8%NT$6.5bn/aPE36.4xn/a0.4%
6652
Eusol BiotechLtd
NT$7.80-3.7%-18.0%NT$1.1bn/aPB2.8xn/an/a
4194
Holy Stone Healthcare
NT$10.20-5.1%-41.4%NT$1.5bn/aPS6.7xn/an/a
4168
GlycoNex Incorporation
NT$24.550.6%-8.7%NT$2.7bn/aPS230.5xn/a0%
6891
Locus Cell
NT$19.90-0.5%-32.3%NT$4.0bn/aPS3826.9xn/an/a
6945
AP Biosciences
NT$57.009.2%-13.6%NT$4.8bn/aPS150.2xn/an/a
6467
Taho Pharmaceuticals
NT$61.501.8%n/aNT$3.1bn/aPB12.9xn/an/a
6808
3D Global Biotech
NT$60.405.2%101.0%NT$4.7bn/aPS85.2xn/an/a
4157
TaiGen Biopharmaceuticals Holdings
NT$11.55-4.9%-23.5%NT$8.3bn/aPE48.3xn/an/a
6657
Energenesis BiomedicalLTD
NT$67.903.8%13.0%NT$6.0bn/aPS813.3xn/an/a
6589
EirGenix
NT$81.20-0.9%-13.2%NT$24.9bNT$127.50PS21.2xE40.1%n/a
6586
CHO Pharma
NT$59.80-2.9%-5.5%NT$12.8bn/aPS11827.9xn/an/a
6709
Advagene Biopharma
NT$19.802.6%-13.9%NT$1.2bn/aPB10.8xn/an/a
6926
Shine-On BioMedicalLtd
NT$66.30-1.8%0.5%NT$3.3bn/aPS346.7xn/an/a
4127
Tien Liang BioTech
NT$38.60-1.0%168.1%NT$1.8bn/aPE121.3xn/a1.3%
4195
Genomics BioSci & Tech.Ltd
NT$18.85-2.6%-5.3%NT$1.4bn/aPS3.3xn/a0%
6949
Pell Bio-Med Technology
NT$146.0012.3%n/aNT$8.4bn/aPS458.4xn/an/a
6549
TaiwanJ Pharmaceuticals
NT$8.992.2%-36.7%NT$720.3mn/aPB12.6xn/an/a
6492
Senhwa Biosciences
NT$45.401.3%1.0%NT$4.0bn/aPS4049xn/an/a
6610
TWi Biotechnology
NT$13.20-2.9%-6.4%NT$1.2bn/aPB4.7xn/an/a
6814
Lukas Biomedical
NT$25.55-2.1%-10.7%NT$1.1bn/aPS5xn/an/a
4170
Vectorite Biomedical
NT$14.151.1%-14.5%NT$619.4mn/aPS11.6xn/an/a
Page 3 of 6